Human Anti-HLA-B27 Recombinant Antibody (clone HD6) (CAT#: HPAB-J0122-YC)

Provided is an antibody, which recognizes HLA-B27 heavy-chain homodimers, termed HC-B27, HLA-B272 or B272, particularly recognizing B272 homodimers and which does not recognize or bind HLA-B27 heterotrimers (B27) including HLA-B27 heterotrimers with β2 microglobulin and peptide. It binds to recombinant B272 complexes but not to HLA-A2, B7 or B27 complexes in ELISA. It could inhibit binding of B272 to KIR3DL1, KIR3DL2 and LILRB2 immunoreceptors and B272-mediated survival and proliferation of human NK cells expressing KIR3DL2.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
FC

Figure 1 Flow cytometric (FACS) analysis of HD6 binding to untransfected LBL721.220 cells.

Figure 1 Flow cytometric (FACS) analysis of HD6 binding to untransfected LBL721.220 cells.

Inhib

Figure 2 HD6 Inhibited B272 Binding to KIR3DL1, KIR3DL2 and LILRB2 Receptors.

Figure 2 HD6 Inhibited B272 Binding to KIR3DL1, KIR3DL2 and LILRB2 Receptors.

Block

Figure 3 Inhibits Apoptosis of KIR3DL2+ Natural Killer Cells Ex Vivo; this Effect is Blocked by HD6.

Figure 3 Inhibits Apoptosis of KIR3DL2+ Natural Killer Cells Ex Vivo; this Effect is Blocked by HD6.


Specifications

  • Host Species
  • Human
  • Type
  • Human IgG1
  • Specificity
  • Human HLA-B27
  • Species Reactivity
  • Human
  • Clone
  • HD6
  • Applications
  • FC, Block, Inhib
  • Related Disease
  • ankylosing spondylitis (AS) and reactive arthritis (ReA or Reiter's syndrome)

Product Property

  • Purity
  • >95% as determined by SDS-PAGE and HPLC analysis
  • Buffer
  • PBS
  • Preservative
  • No preservatives
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Applications

  • Application Notes
  • This antibody has been reported for use in Blocking, Inhibition and Flow Cytometry.

Target

  • Alternative Names
  • Human leukocyte antigen (HLA) B27; B*2701-2759

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone HD6"

See other products for "HLA-B27"

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for HPAB-J0122-YC. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare